Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients
1 other identifier
interventional
80
1 country
1
Brief Summary
This study will be conducted on eighty patients of both sexes with age ranging from 35 to 45years. The will be recovered from COVID-19 infection with chest symptoms. They will be selected from Nasr city police authority hospital. They will be randomly assigned into 3 equal groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 2, 2020
CompletedFirst Submitted
Initial submission to the registry
October 30, 2020
CompletedFirst Posted
Study publicly available on registry
November 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2022
CompletedDecember 28, 2022
December 1, 2022
2.3 years
October 30, 2020
December 24, 2022
Conditions
Outcome Measures
Primary Outcomes (6)
Complete blood picture
A venous blood sample will be taken to be analyzed in the laboratory
change from baseline at 6 weeks
Arterial blood gases
arterial blood sample will be assessed
change from baseline at 6 weeks
6-minute walk Distance
patient will be instructed to walk as fast as long as possible, in a 30 meters obstacle- free corridor, limited by turnaround cones. Standardized verbal encouragement will be given every minute. After 6 min, patient will be instructed to stop, and the total distance will be measured, rounding to the nearest meter.
change from baseline at 6 weeks
Breath-hold test
A rough index of cardiopulmonary reserve measured by the length of time that a person can voluntarily stop breathing; normal duration is 30 seconds or longer; diminished cardiac or pulmonary reserve is indicated by a duration of 20 seconds or less.
change from baseline at 6 weeks
Oxygen saturation
Percentage of haemoglobin saturated with oxygen measured by pulse oximeter
change from baseline at 6 weeks
Borg Dyspnea Scale score
It is a 0 to 10 rated numerical score used to measure dyspnea as reported by the patient during six minute walk test
change from baseline at 6 weeks
Secondary Outcomes (1)
Maximum oxygen consumption
change from baseline at 6 weeks
Study Arms (3)
Group A (Respiratory Training Group)
ACTIVE COMPARATORIt will include 30 patients of both sexes, recovered from COVID-19 infection. In addition to medical drugs, they will receive respiratory training for 6 weeks.
Group B : (Aerobic Training Group)
ACTIVE COMPARATORIt will include 30 patients of both sexes, recovered from COVID-19 infection. In addition to medical drugs, they will receive aerobic training for 6 weeks
Group C : (control group)
NO INTERVENTIONIt will include 20 patients of both sexes, recovered from COVID-19 infection on medical drugs only will receive no exercise as control group.
Interventions
Respiratory training in form of : Diaphragmatic breathing,Segmental breathing, Incentive spirometer:
aerobic exercises are customized according to the patient's underlying disease and residual dysfunction. These exercises will include walking on treadmill. After an initial, 5-minute warm-up phase performed on the treadmill at a low load, each endurance training session lasted 30 minutes and ended with 5-minute recovery and relaxation phase. A total of 3-5 sessions are carried out per week. Patients who are prone to fatigue should perform intermittent exercises
Eligibility Criteria
You may qualify if:
- Patients recovered from COVID -19 infection.
- Patients with body mass index 25 - 35 kg/m2
- Patients previously diagnosed with chest symptoms of COVID- 19 infection.
- Patients' body temperature less than 37.5
- Blood oxygen saturation ≥95%
You may not qualify if:
- Smokers
- Patients with Myocardial infarction
- Patients with diabetes.
- Patients with autoimmune disease.
- Patients with positive COVID -19 infection.
- Patients with previous chest diseases
- a heart rate of \>100 bpm
- a blood pressure of \<90/60 mmHg or \>140/90 mmHg
- a blood oxygen saturation of ≤95%
- other diseases that are not suitable for exercise (osteoarthritis knee - stroke patients, etc)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Police hospital-Nasr city
Cairo, 002, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 30, 2020
First Posted
November 3, 2020
Study Start
July 2, 2020
Primary Completion
October 24, 2022
Study Completion
October 30, 2022
Last Updated
December 28, 2022
Record last verified: 2022-12